Skip to content

Endermotherapy for Children With Developmental Disabilities

Effect of Endermotherapy on Passive Ankle Range of Motion in Children With Developmental Disabilities

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01207570
Enrollment
54
Registered
2010-09-23
Start date
2010-02-28
Completion date
2011-05-31
Last updated
2011-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Developmental Delay

Keywords

flexibility, muscle, stretching, cerebral palsy, developmental

Brief summary

Children with developmental disabilities often sustain decreased range of motion in their extremities. The decrease in flexibility may be due to neuromuscular disorders such as spasticity or dystonia. Other causes may be imbalance in muscle strength surrounding a joint, leading to inappropriate habitual posture. Over time, muscle contracture may result for those muscle groups that are placed in a shortened position for an extended period of time. The most common site of muscle contractures among these children are gastrocnemius/soleus (lower limbs), and latissimus dorsi muscles (upper limbs). Muscle contractures can lead to further decline in functional abilities. Therefore, it is important to identify effective intervention strategies to enhance or maintain muscle flexibility in children with developmental dysfunctions. Commercially available endermotherapy device has been used to soften scar tissue following burn injuries. The mechanical stimulation applied may also have beneficial effects on relaxing the muscle tissue. The overall aim of the proposed study is to determine whether endermotherapy treatment has immediate effect in improving joint range of motion among children with developmental disabilities. The research hypothesis is that children in the endermotherapy group will have significantly more gain in ankle passive range of motion than those in the control group.

Interventions

The subjects will receive a single session of endermotherapy applied to the gastrocnemius/soleus muscle on the more affected side for 5 minutes. The treatment will be conducted by a qualified physiotherapist.

PROCEDUREPassive manual stretching

The subjects will receive a single session of passive manual stretching of the gastrocnemius/soleus muscle on the more affected side. The treatment will be given by a qualified physiotherapist.

Sponsors

Phoelia Co. Ltd.
CollaboratorUNKNOWN
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* children aged between 2 and 6. * children with diagnosis of cerebral palsy or developmental disabilities. * Has limited ankle dorsiflexion range of motion (less than 20 degrees)

Exclusion criteria

* Other serious illnesses that preclude participation

Design outcomes

Primary

MeasureTime frameDescription
Ankle Passive Range of Motionday 1 before treatmentThe ankle passive range of motion will be measured by a Myrin goniometer.

Countries

Hong Kong

Participant flow

Recruitment details

The subjects were recruited from Heep Hong Society, a non-governmental organization that provides rehabilitation services for children with disabilities. The recruitment period was between January 2010 and June 2010.

Pre-assignment details

No significant events.

Participants by arm

ArmCount
Endermotherapy
The subjects in the experimental group will receive a single session (5 minutes) of endermotherapy) applied to the gastrocnemius/soleus muscle group in the more affected side. The treatment will b e carried out by a qualified physiotherapist.
23
Passive Stretching
The subjects in this group will receive a single session of passive stretching of the gastrocnemius/soleus muscle for 5 minutes.
31
Total54

Baseline characteristics

CharacteristicPassive StretchingEndermotherapyTotal
Age, Categorical
<=18 years
31 Participants23 Participants54 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous4.9 years
STANDARD_DEVIATION 1.2
4.7 years
STANDARD_DEVIATION 1.5
4.8 years
STANDARD_DEVIATION 1.3
Region of Enrollment
Hong Kong
31 participants23 participants54 participants
Sex: Female, Male
Female
15 Participants7 Participants22 Participants
Sex: Female, Male
Male
16 Participants16 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 540 / 54
serious
Total, serious adverse events
0 / 540 / 54

Outcome results

Primary

Ankle Passive Range of Motion

The ankle passive range of motion will be measured by a Myrin goniometer.

Time frame: day 1 before treatment

Population: All subjects received the intended treatment protocol and were included in the analysis. ITT was used to analyze the data.

ArmMeasureValue (MEAN)Dispersion
EndermotherapyAnkle Passive Range of Motion8.3 degreeStandard Deviation 8.1
Passive StretchingAnkle Passive Range of Motion10.4 degreeStandard Deviation 6
Primary

Ankle Passive Range of Motion

Ankle passive range of motion at day 4 before the crossover treatment

Time frame: day 4 before treatment

Population: All subjects received the intended treatment protocol and were included in the analysis. ITT was used to analyze the data.

ArmMeasureValue (MEAN)Dispersion
EndermotherapyAnkle Passive Range of Motion11.6 degreeStandard Deviation 6
Passive StretchingAnkle Passive Range of Motion11.3 degreeStandard Deviation 8.3
Primary

Ankle Passive Range of Motion

Ankle dorsiflexion passive range of motion

Time frame: Day 1 after treatment

Population: All subjects received the intended treatment protocol and were included in the analysis. ITT was used to analyze the data.

ArmMeasureValue (MEAN)Dispersion
EndermotherapyAnkle Passive Range of Motion12.2 degreeStandard Deviation 8.6
Passive StretchingAnkle Passive Range of Motion14.9 degreeStandard Deviation 6.7
Primary

Ankle Passive Range of Motion

Ankle passive range of motion on day 4 after the crossover treatment

Time frame: Day 4 after treatment

ArmMeasureValue (MEAN)Dispersion
EndermotherapyAnkle Passive Range of Motion15.9 degreeStandard Deviation 6.7
Passive StretchingAnkle Passive Range of Motion13.5 degreeStandard Deviation 8.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026